Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125823291 | 12582329 | 1 | I | 20160708 | 20160722 | 20160722 | EXP | CN-CIPLA LTD.-2016CN09757 | CIPLA | 0.00 | Y | 0.00000 | 20160722 | OT | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125823291 | 12582329 | 1 | PS | LAMIVUDINE. | LAMIVUDINE | 1 | Oral | 100 MG, QD | U | U | 0 | 100 | MG | ||||||
| 125823291 | 12582329 | 2 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 750 MG/M2, ON DAY 1 | U | U | 0 | 750 | MG/M**2 | ||||||
| 125823291 | 12582329 | 3 | SS | Doxorubicin | DOXORUBICIN | 1 | Unknown | 50 MG/M2, ON DAY 1 | U | U | 0 | 50 | MG/M**2 | ||||||
| 125823291 | 12582329 | 4 | SS | Vincristine | VINCRISTINE | 1 | Unknown | 1.2 G/M2, ON DAY 1 | U | U | 0 | ||||||||
| 125823291 | 12582329 | 5 | SS | ENTECAVIR. | ENTECAVIR | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125823291 | 12582329 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 60 MG/M2, ON DAYS 1 TO 5 | U | U | 0 | 60 | MG/M**2 | ||||||
| 125823291 | 12582329 | 7 | SS | Rituximab | RITUXIMAB | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125823291 | 12582329 | 1 | Prophylaxis |
| 125823291 | 12582329 | 2 | Lymphoma |
| 125823291 | 12582329 | 3 | Lymphoma |
| 125823291 | 12582329 | 4 | Lymphoma |
| 125823291 | 12582329 | 5 | Antiviral treatment |
| 125823291 | 12582329 | 6 | Lymphoma |
| 125823291 | 12582329 | 7 | Lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125823291 | 12582329 | OT |
| 125823291 | 12582329 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125823291 | 12582329 | Condition aggravated | |
| 125823291 | 12582329 | Hepatic encephalopathy | |
| 125823291 | 12582329 | Hepatic failure | |
| 125823291 | 12582329 | Hepatitis B DNA increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |